Dupuytren’s contracture treated with botulinum toxin A injection

Shane Michael Davis, Eric Yao Chang


Dupuytren’s contracture is a condition in which fibromatosis of the palmar and digital fascia can lead to painful contractures of the hand. Common conservative treatments are of limited efficacy, while invasive options have risk of adverse effects. A 57-year-old female presented with chronic, bilateral hand pain secondary to Dupuytren’s contractures. Traditional conservative treatments did not provide relief. She received a series of three botulinum toxin A injections into the palmar fascia of both hands, resulting in four months of improved hand function and pain relief. This case presents a novel treatment for Dupuytren’s contracture using botulinum toxin injection. Botulinum toxin has inhibitory effects on the neuromuscular junction and pain signaling pathways to relax muscles and reduce pain. We believe its action on this patient’s intrinsic hand muscles resulted in her improved hand function. Botulinum toxin injection can be considered as a treatment option for Dupuytren’s contracture.


Dupuytren contracture; botulinum toxin; hand; pain; injections

Full Text:



Shum DT, McFarlane RM. Histogenesis of Dupuytren’s disease: An immunohistochemical study of 30 cases. J Hand Surg Am 1988; 13A(1):61-67.


Tan K, Withers AHJ, Tan ST, Itinteag T. The role of stem cells in dupuytren’s disease: A review. Plast Reconstr Surg - Glob Open 2018;6:1–5. doi:10.1097/GOX.0000000000001777.

Townley WA, Baker R, Sheppard N, et al. Dupuytren’s contracture unfolded. Br Med J 2006;332:397–400. doi:10.1136/bmj.332.7538.397

Tubiana R. Dupuytren’s disease of the radial side of the hand. Hand Clin 1999; 15(1):149-159.

Larocerie-Salgado J, Davidson J. Nonoperative treatment of PIPJ flexion contractures associated with Dupuytren’s disease. J Hand Surg Eur Vol 2012;37:722–727. doi:10.1177/1753193411422680.

Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg Am 2000; 25(6):1157-1162. doi:10.1053/jhsu.2000.18493.

Ball C, Izadi D, Verjee LS, Chan J, Nanchahal J. Systematic review of non-surgical treatments for early dupuytren’s disease. BMC Musculoskelet Disord 2016; 17(1):345. doi:10.1186/s12891-016-1200-y.

Feldman G, Rozen N, Rubin G. Dupuytren’s contracture: Current treatment methods. Isr Med Assoc J 2017;19:648–650.

Peimer CA, Blazar P, Coleman S, et al. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium Histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data. J Hand Surg Am 2015; 40(8):1597-1605. doi:10.1016/j.jhsa.2015.04.036.

Rayan GM. Nonoperative treatment of Dupuytren’s disease. J Hand Surg Am 2008; 33(7):1208-1210. doi:10.1016/j.jhsa.2008.05.027.

Brown EA, Schütz SG, Simpson DM. Botulinum toxin for neuropathic pain and spasticity: an overview. Pain Manag 2014; 4(2):129-151. doi:10.2217/pmt.13.75.

De Paiva A, Meunier FA, Molgó J, Aoki KR,

Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A 1999; 96(6):3200-3205. doi:10.1073/pnas.96.6.3200.

DOI: http://dx.doi.org/10.22551/2020.29.0704.10175

Copyright (c) 2021 Shane Michael Davis, Eric Yao Chang

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975